140
Participants
Start Date
February 19, 2015
Primary Completion Date
September 7, 2017
Study Completion Date
September 7, 2017
Tralokinumab
Tralokinumab dose
Placebo
Placebo dose
Research Site, Brussels (Anderlecht)
Research Site, Woluwé-St-Lambert
Research Site, Leuven
Research Site, Hasselt
Research Site, Ghent
Research Site, The Bronx
Research Site, Berlin
Research Site, Berlin
Research Site, Rochester
Research Site, Monroeville
Research Site, Philadelphia
Research Site, Vinnytsia
Research Site, Hamburg
Research Site, Richmond
Research Site, Durham
Research Site, Spartanburg
Research Site, Anderson
Research Site, Hanover
Research Site, Pessac
Research Site, Clearwater
Research Site, Grenoble
Research Site, Nantes
Research Site, Dnipro
Research Site, Mainz
Research Site, Lille
Research Site, Frankfurt
Research Site, Kharkiv
Research Site, Kharkiv
Research Site, St Louis
Research Site, Lyon
Research Site, Dallas
Research Site, Tyler
Research Site, Boerne
Research Site, San Antonio
Research Site, München
Research Site, München-Pasing
Research Site, New Haven
Research Site, Amsterdam
Research Site, Groningen
Research Site, Leeuwarden
Research Site, Bystra
Research Site, Krakow
Research Site, Krakow
Research Site, Lodz
Research Site, Lubin
Research Site, Ostrowiec Świętokrzyski
Research Site, Rzeszów
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Kyiv
Research Site, Kyiv
Lead Sponsor
AstraZeneca
INDUSTRY